Modified Intimation of Board meeting w.r.t disclosure of Trading Window closure in continuation to intimation submitted on November 07, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory has called a Board meeting on November 12, 2025, at 11:30 AM via video conferencing. The Board will consider and approve the Un-Audited Financial Results for the half year ended September 30, 2025, along with the Limited Review Report. Additionally, the Board will consider and approve the formation of a subsidiary company. The trading window for designated persons, promoters, directors, and insiders has been closed from October 1, 2025, and will remain closed until 48 hours after the financial results are announced on November 12, 2025.
Shareholders should watch for the half-yearly results on November 12, 2025, which could influence the stock price. The proposed subsidiary formation, if approved, may signal a new business expansion or diversification move, though the financial impact is not yet clear from this intimation.